Hirsingue, France

Dominique Grimler

USPTO Granted Patents = 6 


Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Location History:

  • Hirsingue, FR (2010 - 2012)
  • Basel, CH (2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Dominique Grimler

Introduction

Dominique Grimler is a notable inventor based in Hirsingue, France. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on chemical processes and novel pharmaceutical compounds.

Latest Patents

Among his latest patents is a chemical process for preparing spiroindolones and intermediates thereof. This invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds, including (1'R,3′S)-5,7′-dichloro-6′-fluoro-3′-methyl-2′,3′,4′,9′-tetrahydrospiro[indoline-3,1′-pyrido[3,4-b]indol]-2-one and its salts, hydrates, and solvates. Another significant patent involves optical isomers of an iloperidone metabolite, which pertains to novel isomers of a metabolite of Iloperidone, their preparation, and their use as pharmaceuticals and pharmaceutical compositions.

Career Highlights

Dominique Grimler is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative pharmaceutical solutions that address various medical needs.

Collaborations

Throughout his career, Grimler has collaborated with esteemed colleagues such as Gottfried Sedelmeier and Murat Acemoglu. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Dominique Grimler's contributions to the field of pharmaceuticals through his innovative patents highlight his expertise and commitment to advancing medical science. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…